期刊文献+

PD-L1蛋白过表达对HeLa细胞迁移能力的影响 被引量:3

Effect of PD-L1 overexpression on HeLa cell migration
原文传递
导出
摘要 [目的]探讨PD-L1过表达对HeLa细胞迁移的影响。[方法]通过分子克隆构建PD-L1质粒载体(p EGFPPD-L1);通过PEI法转染质粒,调节质粒转染量(1μg、3μg、5μg)和转染时间(24 h、36 h、48 h、72 h),优化转染条件;通过细胞划痕实验检测细胞融合率,Western Blot检测细胞迁移相关蛋白(E-钙黏蛋白、N-钙黏蛋白、波形蛋白)的表达量。[结果]最佳转染条件是质粒量3μg/孔,转染后48 h观察,此时转染效率可达(82.94±8.08)%。转染pEGFP-PD-L1质粒后,HeLa细胞的PD-L1过表达3.5倍,划痕融合率显著增高(p<0.01);波形蛋白和N-钙黏蛋白的表达量显著升高(p<0.05),E-钙黏蛋白表达量显著下降(p<0.05)。[结论]PD-L1过表达显著促进HeLa细胞迁移能力和上皮向间质转化水平。 [Objective]To investigate the effect of PD-L1 overexpression on HeLa cell migration.[Methods]PD-L1 overexpression plasmid(pEGFP-PD-L1) was constructed by molecular cloning technique and transfected into HeLa cell by PEI method.The optimized transfection condition was chosen by adjusting plasmid quantity(1 μg,3 μg,5 μg) and transfection time(24 h,36 h,48 h,72 h).Cell fusion efficiency was detected by wound healing assay.Vimentin,E-cadherin,and N-cadherin proteins expression levels were detected by Western Blot assay.[Results] The optimized transfection condition was adding 3μg/well plasmid and 48 h transfection time.The highest transfection efficiency was(82.94 ± 8.08) %.After plasmid transfection,PD-L1 expression was 3.5 times higher than untransfected group and the wound area healing efficiency was significantly increased(p 〈 0.01).Vimentin and N-cadherin protein expressions were significantly increased and E-cadherin protein expression was significantly decreased(p 〈 0.05).[Conclusion] PD-L1 overexpression promotes HeLa cell migration and the level of epithelial-mesenchymal transition.
出处 《生物技术》 北大核心 2017年第6期557-562,共6页 Biotechnology
基金 国家自然科学基金项目("MRTF-A和STAT3调控乳腺癌EMT及机制研究" No.31501149 "抗活性氧自由基的载白藜芦醇Ti O2纳米管促进骨修复研究" No.31700824)
关键词 PD-L1 免疫治疗 细胞迁移 上皮向间质转化 PD-L1 immunotherapy cell migration epithelial-mesenchymal transition
  • 相关文献

参考文献6

二级参考文献56

  • 1Ishida Y, Agata Y, Shibahara K, et al. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death[ J]. EMBO J, 1992, 11 ( 11 ) : 3887 - 2895.
  • 2Okazaki T, Wang J. PD-1/PD-L pathway and autoimmunity[J]. Autoimmunity, 2005, 38(5): 353-357.
  • 3Li B, VanRoey M, Wang C, et al. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor-secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors [ J ]. Clin Cancer Res, 2009, 15 ( 5 ) : 1623 - 1634.
  • 4Okudaira K, Hokari R, Tsuzuki Y, et al. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model[J]. Int J Oncol, 2009, 35(4) : 741 -749.
  • 5Iwai Y, Ishida M, Tanaka Y, et al. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunothempy by PD-L1 blockade [ J ]. Proc Natl Acad Sci U S A, 2002, 99 (19) : 12293 - 12297.
  • 6Dulos J, Carven GJ, van Boxtel SJ, et al. PD-1 blockade augments Thl and Thl7 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer [J]. J Immunother, 2012, 35 (2) : 169 - 178.
  • 7Kaba SA, Brando C, Guo Q, et al. A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria[ J]. J Immunol, 2009, 183 ( 11 ) : 7268 - 7277.
  • 8Kanai T, Totsuka T, Uranshihara K, et al. Blockade of B7-H1 Suppresses the Development of Chronic Intestinal Inflammation[J]. J Immunol, 2003, 171 (8) : 4156 -4163.
  • 9Konishi J, Yamazaki K, Azuma M, et al. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression [ J ]. Clin Cancer Res, 2004, 10(15): 5094-5100.
  • 10Radziewicz H, Ibegbu CC, Fernandez ML, et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression[J]. J Virol, 2007, 81(6): 2545-2553.

共引文献82

同被引文献12

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部